dermatomyositis

Juvenile dermatomyositis, a rare but often severe and chronic systemic autoimmune disease, includes a large number of…
Read More...

BRISBANE, Oct. 18, 2022 (GLOBE NEWSWIRE) -- A recent study report released by Data Bridge Market research with titled…
Read More...

Physician’s Briefing Staff WEDNESDAY, Oct. 5, 2022 (HealthDay News) --…
Read More...

A recent study in the Journal of Investigative Dermatology describes the success of using lenabasum, a cannabinoid…
Read More...

Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1; in all five placebo-controlled…
Read More...

Patients with…
Read More...

The FDA approved…
Read More...

Treatment with intravenous immunoglobulins (IVIG) for…
Read More...